<DOC>
	<DOCNO>NCT01338636</DOCNO>
	<brief_summary>The purpose study asses whether ambrisentan help people Exercised Induced Pulmonary Arterial Hypertension . The investigator also want find ambrisentan safe take without cause excessive side effect .</brief_summary>
	<brief_title>An Open-Label Uncontrolled Study Safety Efficacy Ambrisentan Patients With Exercise Induced Pulmonary Arterial Hypertension</brief_title>
	<detailed_description>Exercised Induce Pulmonary Arterial Hypertension ( EIPAH ) population : These patient may provide unique window pathogenesis PAH . Our data suggest patient may represent early phase PAH abnormal vascular response . The study include assessment potential impact ambrisentan exercise capacity Advanced Level-3 CPET , New York Heart Association ( NYHA ) functional class .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>The subject provide write informed consent commencement study related procedure . The subject 18 year age old . If female subject childbearing potential , subject must agree use 2 form contraceptive therapy , include least 1 barrier method , throughout study followup . ( Women surgically sterile postmenopausal least 2 year consider childbearing potential . ) The subject finding either exercise induced PAH Advanced Level 3 CPET perform within last 6months NYHA Class I II . The subject LVEF 55 % , obtain appropriate method ( i.e. , ECHO , radionuclide imaging , cardiac catheterization ) The subject take stable concomitant medication regimen least 4 week prior enrollment study expect change study period followup . Changes diuretic and/or nitrate therapy need study period acceptable .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Exercised induced pulmonary arterial hypertension</keyword>
	<keyword>Pulmonary hypertension</keyword>
	<keyword>ambrisentan</keyword>
	<keyword>Advanced cardiopulmonary exercise test</keyword>
</DOC>